Shares of Johnson & Johnson JNJ, +1.83% rose 1.83% to $149.66 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +1.40% rising 1.40% to 3,380.35 and the Dow Jones Industrial Average DJIA, +1.04% rising 1.05% to 27,976.84. The stock’s rise snapped a two-day losing streak. Johnson & Johnson closed $7.34 below its 52-week high ($157.00), which the company achieved on April 23rd.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. RHHVF, +2.42% rose 2.42% to $346.13, Merck & Co. Inc. MRK, +2.18% rose 2.19% to $82.68, and Pfizer Inc. PFE, +1.42% rose 1.43% to $38.33. Trading volume (5.2 M) remained 1.4 million below its 50-day average volume of 6.6 M.